259 related articles for article (PubMed ID: 21724833)
1. Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'.
Lin G; Aranda V; Muthuswamy SK; Tonks NK
Genes Dev; 2011 Jul; 25(13):1412-25. PubMed ID: 21724833
[TBL] [Abstract][Full Text] [Related]
2. Suppression of protein tyrosine phosphatase N23 predisposes to breast tumorigenesis via activation of FYN kinase.
Zhang S; Fan G; Hao Y; Hammell M; Wilkinson JE; Tonks NK
Genes Dev; 2017 Oct; 31(19):1939-1957. PubMed ID: 29066500
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
[TBL] [Abstract][Full Text] [Related]
4. A novel phosphatidic acid-protein-tyrosine phosphatase D2 axis is essential for ERBB2 signaling in mammary epithelial cells.
Ramesh M; Krishnan N; Muthuswamy SK; Tonks NK
J Biol Chem; 2015 Apr; 290(15):9646-59. PubMed ID: 25681440
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin.
Wang Y; Cao J; Liu W; Zhang J; Wang Z; Zhang Y; Hou L; Chen S; Hao P; Zhang L; Zhuang M; Yu Y; Li D; Fan G
J Biol Chem; 2019 Nov; 294(48):18306-18323. PubMed ID: 31653698
[TBL] [Abstract][Full Text] [Related]
6. The catalytically inactive tyrosine phosphatase HD-PTP/PTPN23 is a novel regulator of SMN complex localization.
Husedzinovic A; Neumann B; Reymann J; Draeger-Meurer S; Chari A; Erfle H; Fischer U; Gruss OJ
Mol Biol Cell; 2015 Jan; 26(2):161-71. PubMed ID: 25392300
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
[TBL] [Abstract][Full Text] [Related]
8. Receptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility.
Boivin B; Chaudhary F; Dickinson BC; Haque A; Pero SC; Chang CJ; Tonks NK
J Biol Chem; 2013 Dec; 288(52):36926-35. PubMed ID: 24217252
[TBL] [Abstract][Full Text] [Related]
9. Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition.
Nilsson GM; Akhtar N; Kannius-Janson M; Baeckström D
Int J Oncol; 2014 Jul; 45(1):82-94. PubMed ID: 24807161
[TBL] [Abstract][Full Text] [Related]
10. Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.
Chaudhary F; Lucito R; Tonks NK
Biochem J; 2015 Jan; 465(1):89-101. PubMed ID: 25287652
[TBL] [Abstract][Full Text] [Related]
11. RPTPα controls epithelial adherens junctions, linking E-cadherin engagement to c-Src-mediated phosphorylation of cortactin.
Truffi M; Dubreuil V; Liang X; Vacaresse N; Nigon F; Han SP; Yap AS; Gomez GA; Sap J
J Cell Sci; 2014 Jun; 127(Pt 11):2420-32. PubMed ID: 24652832
[TBL] [Abstract][Full Text] [Related]
12. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
Steelant WF; Goeman JL; Philippé J; Oomen LC; Hilkens J; Krzewinski-Recchi MA; Huet G; Van der Eycken J; Delannoy P; Bruyneel EA; Mareel MM
Int J Cancer; 2001 May; 92(4):527-36. PubMed ID: 11304687
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine phosphatase HD-PTP (PTPN23) is degraded by calpains in a calcium-dependent manner.
Castiglioni S; Maier JA
Biochem Biophys Res Commun; 2012 May; 421(2):380-3. PubMed ID: 22510412
[TBL] [Abstract][Full Text] [Related]
14. The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis.
Díaz-Valdivia NI; Díaz J; Contreras P; Campos A; Rojas-Celis V; Burgos-Ravanal RA; Lobos-González L; Torres VA; Perez VI; Frei B; Leyton L; Quest AFG
Oncogene; 2020 Apr; 39(18):3693-3709. PubMed ID: 32152405
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin surface levels in epithelial growth factor-stimulated cells depend on adherens junction protein shrew-1.
Gross JC; Schreiner A; Engels K; Starzinski-Powitz A
Mol Biol Cell; 2009 Aug; 20(15):3598-607. PubMed ID: 19515834
[TBL] [Abstract][Full Text] [Related]
16. Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer.
Manteghi S; Gingras MC; Kharitidi D; Galarneau L; Marques M; Yan M; Cencic R; Robert F; Paquet M; Witcher M; Pelletier J; Pause A
Cell Rep; 2016 May; 15(9):1893-900. PubMed ID: 27210750
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin binding modulates EGF receptor activation.
Fedor-Chaiken M; Hein PW; Stewart JC; Brackenbury R; Kinch MS
Cell Commun Adhes; 2003; 10(2):105-18. PubMed ID: 14681060
[TBL] [Abstract][Full Text] [Related]
18. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.
Yuan T; Wang Y; Zhao ZJ; Gu H
J Biol Chem; 2010 May; 285(20):14861-14870. PubMed ID: 20335174
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration.
Müller T; Choidas A; Reichmann E; Ullrich A
J Biol Chem; 1999 Apr; 274(15):10173-83. PubMed ID: 10187801
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas.
Masuelli L; Budillon A; Marzocchella L; Mrozek MA; Vitolo D; Di Gennaro E; Losito S; Sale P; Longo F; Ionna F; Lista F; Muraro R; Modesti A; Bei R
J Cell Physiol; 2012 Sep; 227(9):3344-53. PubMed ID: 22213373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
